Submitted by web@researchtop... on Mon, 08/02/2010 - 12:48
Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from August 3, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from presentations at ASCO 2010 and transcribed comments from recent interviews with Richard M Goldberg, MD (6/23/10) and Axel Grothey, MD (7/9/10)
Bokemeyer C et al. Cetuximab with chemotherapy (CT) as first-line treatment for metastatic colorectal cancer (mCRC): Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status. Proc ASCO 2010;Abstract 3506.
Alberts SR et al. Adjuvant mFOLFOX6 with or without cetuximab in K-RAS wild type patients with resected stage III colon cancer: Results from NCCTG Intergroup phase III trial N0147. Proc ASCO 2010;Abstract CRA3507.
Goldberg RM et al. Adjuvant mFOLFOX6 plus or minus cetuximab in patients with K-RAS mutant resected stage III colon cancer: NCCTG Intergroup phase III trial N0147. Proc ASCO 2010;Abstract 3508.